Robert Sievers of Aktiv-Dry LLC in the United States, one of the original Grand Challenges in Global Health grantees, has developed an inhalant vaccine for measles, currently in Phase I clinical trials. Learn more about this project to create a needle-free immunization strategy for the developing world.